УДК:  616-053.2

Автор статьи:  Потапов А.С.

Соавторы:  Татьянина О.Ф., Цимбалова Е.Г., Кучеренко А.Г., Намазова Л.С.

Место работы автора:  Научный центр здоровья детей РАМН, Москва

Название журнала:  Педиатрия и детская хирургия

Год выпуска:  2008

Номер журнала:  4(54)

Страницы:  с.17-22

Список литературы:  
1. Адлер Г. Болезнь Крона и язвенный колит: Пер. с нем. Шептулина А.А. – М.: ГЭОТАР-МЕД, 2001.-500 с.
2. Алиева Э.И., Румянцев В.Г. Болезнь Крона у детей // Педиатрия. – 2001.- №6
3. Белоусова Е.А. Язвенный колит и болезнь Крона. – Тверь: ООО Издательство «Триада». – 2002. – 8стр.
4. Белоусова Е.А. иммунные механизмы при воспалительных заболеваниях кишечника и принципы селективной иммунокоррекции. // Материалы 15 Юбилейной школы-семинара им. А.М. Уголева «Современные проблемы физиологии и патологии пищеварения», 1999.- С.48-56
5. Михайлова Е.И., Пиманов С.И., Воропаев Е.И., Тимашова В.Р. Фекальный маркер язвенного колита // Российский журнал гастроэнтерологии, гепатологии и колопроктологии. – 2007. № 5. – С. 60-63.
6. Румянцев В.Г., Щиголева Н.Е. Болезнь Крона у детей // Consillium medicum. – 2002.- Т.4 №6. – С. 20-23.
7. Яблокова Е.А., Горелов А.В., Ратникова М.А., Сичинава И.В. и др. Воспалительные заболевания кишечника у детей // Педиатрия. – 2006.- №5.- С.99-102.
8. Щербаков П.Л. Воспалительные заболевания кишечника у детей: болезнь Крона и неспецифический язвенный колит. // Детский доктор. – 2000.- №4 - С. 22-26.
9. Andus T, Gross V, Caesar I, et al. PMN-elastase in assessment of patients with inflammatory bowel disease. Dig Dis Sci 1993; 38:1638–44.
10. Adeyemi EO, Neumann S, Chadwick VS, et al. Circulating human leucocyte elastase in patients with inflammatory bowel disease. Gut 1985; 26:1306–11.
11. Bohe M, Genell S, Ohlsson K. Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease. Scand J Gastroenterol 1986; 21:598–604
12. Braegger CP, Nicholls S, Murch SH, et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992; 339:89–91.
13. Bunn SK. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001; 32:171-177.
14. Bunn SK, et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001; 33:14-22.
15. Bischoff SC, Grabowsky J, Manns MP. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 1997; 42:394–403.
16. Berstad A, Borkje B, Riedel B, et al. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepato-Gastroenterol 1993; 40:276–8.
17. Berni Canani R. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis. 2004; 36:467-470.
18. Costa F, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis. 2003; 35:642-647.
19. Carroccio A. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem. 2003; 49(pt 1):861-867.
20. Berni Canani R. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2006; 42:9-15.
21. Campeotto F. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed. 2004; 89:F353-F355.
22. Denizot Y, Chaussade S, Nathan N, et al. PAF-acether and acetylhydrolase in stool of patients with Crohn’s disease. Dig Dis Sci 1992; 37:432–7
23. Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983; 134:1–6.
24. Fischbach W, Becker W, Mossner J, et al. Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut 1987; 28:386–93.
25. Fagerhol MK, Andersson KB, Naess-Andresen CF, et al. Calprotectin (the L1 leukocyte protein). In: Smith VL, Dedman JR, eds.Stimulus Response Coupling: The Role of Intracellular Calciumbinding Proteins. Boston, Boca Raton: CRC Press; 1990:187–210.
26. Golden BB. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr. 2002; 34:324. Letter.
27. Husebye E, Ton H, Johne B. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm. Am J Gastroenterol. 2001; 96:2683-2687.
28. Loonen H.J., Griffiths A.M., et al. A critical assessment of items on the Pediatric Crohn's Disease Activity Index // Pediatr. Gastroenterol. Nutr. – 2003. – Vol. 36. №1. – P. 90-95
29. Olafsdottir E. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr. 2002; 91:45-50.
30. Nicholls S, Stephens S, Braegger CP, et al. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J Clin Pathol 1993; 46:757–60.
31. Nissen AC. Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr. 2004; 38:107-108.
32. Ravikumara M., Sandhu B.K. Epidemiology of inflammatory bowel diseases in childhood // Indian. J. Pediatr. -2006.- Vol.73. - №8. – P.717-721.
33. Roseth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27:793–8.
34. Roseth AG, Aadland E, Jahnsen J, et al. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997; 58:176–80.
35. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. 1999; 34:50-54.
36. Rachmilewitz D., Coated mesalazine versus sulfasalazine in the treatment of active ulcerative colitis: a randomized trial // B.M.J. -1989. – Vol.82. – P.82
37. Saiki T, Mitsuyama K, Toyonaga A, et al. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol 1998; 33:616–22
38. Tibble JA. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut. 1999; 45:362-366.
39. Ton H, et al. Improved assay for fecal calprotectin. Clin Chim Acta.2000; 292:41-54.
40. Tibble J, et al. A simple method for assessing intestinal inflammation in Crohn_s disease. Gut. 2000; 47
41. Ulrika Lorentzon Fagerberg, Journal of Pediatric Gastroenterology and Nutrition 2002; 37:468–472.

Электронный вариант:  скачать

---